Supreme Court Strikes Down Prometheus Patents | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Supreme Court today invalidated two patents held by Prometheus Laboratories in a widely watched case for those involved in the personalized medicine field.

In a unanimous decision, the court called the patents in dispute, US Patent Nos. 6,355,623 and 6,680,302 unpatentable because they merely describe the laws of nature and "add nothing specific to the laws of nature other than what is well-understood, routine, conventional activity."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.